Global Health Limited, operating under the brand name Medanta, is a prominent healthcare provider in India, known for its multi-specialty tertiary care hospitals. Medanta hospitals offer advanced medical treatments across a wide range of specialties, including cardiology, oncology, neurology, orthopedics, and more. The company is renowned for its state-of-the-art infrastructure, cutting-edge technology, and a team of highly skilled doctors and medical professionals. Medanta’s focus on providing world-class healthcare has made it a trusted name in India and internationally, attracting patients seeking high-quality medical care, innovative treatments, and personalized patient experiences.
PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (INR Cr) | 2384 -13.7% | 2761 25.0% | 2209 48.9% | 1483 -4.0% | 1544 2.5% | 1506 8.2% | 1392 3.6% | 1344 -5.8% | 1427 16.0% | 1230 11.5% | 1103 - |
Net Operating Income (INR Cr) | 2280 15.53% | 2694 24.31% | 2167 49.81% | 1447 -3.58% | 1500 3.06% | 1456 0.00% | 1343 0.00% | 1277 -7.72% | 1382 15.73% | 1194 0.00% | 1070 0.00% |
Profit (INR Cr) | 361 10.7% | 326 66.2% | 196 581.0% | 29 -20.7% | 36 -29.2% | 51 56.1% | 33 -39.5% | 54 -68.1% | 170 15.7% | 147 10.4% | 133 - |
Assets (INR Cr) | 3187 -13.0% | 3664 29.4% | 2832 18.4% | 2392 1.7% | 2354 9.6% | 2147 27.1% | 1689 21.9% | 1385 15.0% | 1205 27.5% | 944 12.5% | 839 - |
Net Worth (INR Cr) | 2849 14.5% | 2428 50.3% | 1616 16.9% | 1382 2.4% | 1350 4.2% | 1295 0.0% | 1185 0.0% | 1119 8.2% | 1024 21.0% | 847 0.0% | 698 0.0% |
Employee Cost (INR Cr) | 591 -6.8% | 634 11.7% | 568 21.8% | 466 -13.5% | 539 -0.4% | 541 2.7% | 527 1.7% | 518 9.8% | 472 11.8% | 422 14.4% | 369 - |
Interest Cost (INR Cr) | 30 | 86 | 86 | 73 | 57 | 38 | 28 | 19 | 14 | 9 | 32 |
Cash & Bank Balance (INR Cr) | 959 | 1278 | 512 | 289 | 250 | 266 | 260 | 469 | 376 | 304 | 234 |
Total Debt (INR Cr) | 260 | 1122 | 1109 | 931 | 929 | 787 | 423 | 183 | 133 | 48 | 70 |
PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|---|
Profit As % Of Revenues | 15.1% | 11.8% | 8.9% | 1.9% | 2.4% | 3.4% | 2.4% | 4.0% | 11.9% | 12.0% | 12.1% |
Profit As % Of Assets | 11.3% | 8.9% | 6.9% | 1.2% | 1.5% | 2.4% | 2.0% | 3.9% | 14.1% | 15.6% | 15.9% |
Profit As % Of Networth | 12.7% | 13.4% | 12.1% | 2.1% | 2.7% | 4.0% | 2.8% | 4.9% | 16.6% | 17.4% | 19.1% |
Interest Cost to EBITDA % | 6.1% | 13.9% | 18.8% | 36.9% | 29.5% | 21.9% | 22.6% | 16.1% | 4.7% | 3.4% | 12.9% |
Debt to Equity Ratio | 0.09 | 0.46 | 0.69 | 0.67 | 0.69 | 0.61 | 0.36 | 0.16 | 0.13 | 0.06 | 0.10 |
RONW | 13.5% | 16.1% | 13.1% | 2.1% | 2.8% | 4.0% | 2.8% | 5.1% | 18.2% | 17.3% | 19.1% |
ROCE | 17.2% | 16.5% | 14.1% | 4.4% | 5.4% | 5.6% | 5.2% | 8.1% | 25.7% | 24.9% | 28.3% |